Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial

BACKGROUND: Moderate to severe psoriasis is a systemic inflammatory disease associated with insulin resistance, obesity and type 2 diabetes (T2DM). Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that improves glycaemia and has a marketing authorisation for the treatment of T2DM. Non-immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynch, Maeve, Ahern, Tomás B., Timoney, Irene, Sweeney, Cheryl, Kelly, Genevieve, Hughes, Rosalind, Tobin, Anne-Marie, O’Shea, Donal, Kirby, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714444/
https://www.ncbi.nlm.nih.gov/pubmed/26767505
http://dx.doi.org/10.1186/s13063-016-1157-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714444/
https://www.ncbi.nlm.nih.gov/pubmed/26767505
http://dx.doi.org/10.1186/s13063-016-1157-z

Ejemplares similares